Hutchinson Clinic, Pa

Hutchinson, Kansas 67502

1 studies enrolling now · 19 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Breast Cancer, Cardiovascular Disease, Chronic Idiopathic Constipation, Coronary Artery Disease, Cryptogenic Sensory Polyneuropathy, Diabetic Kidney Disease, Lymphoma, Melanoma, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer

Studies at this site

• OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
• A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN — Completed
• RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women. — Completed
• A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer — Stopped early
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas — Completed
• Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease — Completed
• The Plecanatide Chronic Idiopathic Constipation (CIC) Study — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations — Completed
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• Study of Immunotherapy to Treat Advanced Prostate Cancer — Completed
• Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer — Completed
• MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer — Completed
• Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma — Completed
• Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma — Status unconfirmed
• A Multiple Myeloma Trial in Patients With Bone Metastases — Completed
• Trial of Myocet in Metastatic Breast Cancer — Status unconfirmed
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) — Stopped early